About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Dana-Farber Cancer Institute
https://www.dana-farber.org/
2023-2024 EMBRACE MBC Virtual Forum Series
ASCO® GU 2024
ASCO® 2023
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Breast
Lung
Gynecologic
Genitourinary
Gastrointestinal
Colorectal
Basic Science
Supportive and Palliative Care
CNS
Skin
Head and Neck
Business
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
Bladder Cancer Highlights From ASCO® GU 2024
By
Dana-Farber Cancer Institute
FEATURING
Charlene Mantia
,
Joaquim Bellmunt
By
Dana-Farber Cancer Institute
FEATURING
Charlene Mantia
,
Joaquim Bellmunt
119 views
March 13, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
ASCO® GU 2024
22:03
Dana-Farber Cancer Institute
RCC Highlights From ASCO® GU 2024
Feat.
W. Xu,
T. Choueiri
02:31
Dana-Farber Cancer Institute
Testicular Cancer Highlights From ASCO® GU 2024
Feat.
A. Tewari
22:58
Dana-Farber Cancer Institute
Bladder Cancer Highlights From ASCO® GU 2024
Feat.
C. Mantia,
J. Bellmunt
23:03
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
Feat.
J. Berchuck,
A. Choudhury
02:23
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Association of DAZL Expression With Ri…
Feat.
A. Tewari
02:31
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Rate of Hospitalization and Length of …
Feat.
A. Morgans
02:35
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "OS Results From the KEYNOTE-564 Study …
Feat.
T. Choueiri
02:38
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Impact of Race on Outcomes to 177Lu-PS…
Feat.
A. Rami
02:22
Dana-Farber Cancer Institute
ASCO® GU 2024 Insights: "Patient Characteristics, Treatment Pat…
Feat.
X. Wei
